Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 90 years old who were discharged from Ocean University Medical Center (OUMC)
- People who were admitted to hospital for a flare-up of a type of heart failure called heart failure with preserved ejection fraction (HFpEF)
- People who were sent home after their hospital stay, either with or without home care support
Who may not be able to join:
- People who do not wish to take part in follow-up phone calls as part of the trial
- People who were discharged to a care facility rather than their own home
- People who were discharged with professional home care services in place
- People who were discharged onto hospice (end-of-life care) services
- People who are on kidney dialysis (haemodialysis)
- People who left the hospital against medical advice
- People who are pregnant
- People who have been diagnosed with dementia
- People who are not able to make their own medical decisions or provide their own consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alexandria Berns, PharmD, Hackensack Meridian Health
Phone: 7328405100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All-cause 30-day hospital readmission rate for heart failure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.